FDA Backs Ketamine to Treat This Rare and Debilitating Pain Syndrome
Food and Drug Administration grants psychedelic biotechnology company PharmaTher orphan drug designation for ketamine to treat complex regional pain syndrome.
Psychedelic Spotlight News
Interview with Joseph Mays, IRI Program Director at Chacruna
In our conversation with Joseph, we chat a bit about some critical topics such as how psychedelics can allow us to understand the Indigenous philosophy of interrelatedness between one another and our ecosystems, the importance of considering sacred reciprocity to Indigenous peoples and their land, and how Chacruna’s Indigenous Reciprocity Initiative is making it simple for companies to give back to the societies who have cultivated psychedelic medicine.
You Can Now Buy Marley One Functional Mushrooms on Amazon
Silo Wellness CEO Douglas K. Gordon tells Psychedelic Spotlight that this is a “crucial” step toward “the mainstream acceptance of psychedelics and overall de-stigmatization of mushrooms, by way of the functional category.”
Pennsylvania Lawmakers File Psilocybin Research Bill for Veterans and First Responders
“As traditional treatment has proven inadequate at both the individual and public health level, the Commonwealth has a responsibility to research alternative options,” the bill’s sponsors write in a memo.
On Sacred Reciprocity: Giving Back to our Indigenous Predecessors in the Psychedelic Movement
We owe so much of our understanding of these compounds to Indigenous peoples, and the widespread bioprospecting projects taking place today would not be prevalent without the inherent harm placed on local groups historically.
How Mindset Pharma Is Making and Defining ‘Next-Generation Psychedelic Drugs’
CEO James Lanthier compares psychedelic medicines to aspirin, and explains why the company’s lead candidate may be better than psilocybin.
Arcata Becomes Third California City to Decriminalize Psychedelics
Planting, cultivating, purchasing, transporting, distributing, possessing these plants and fungi will be the lowest law enforcement priority for the city.
Psychedelic Business Spotlight: October 8, 2021
This week in psychedelic business news: Enveric Biosciences uses AI to identify viable psychedelic drug candidates; Novamind launches end-of-life palliative care program; and PharmaTher tests ketamine to treat Parkinson’s Disease.
These Are the Best Areas to Forage for Psychedelic Mushrooms in the United States
A new study describes the Pacific Northwest as “by far the best place in America to go looking for psychedelic mushrooms.”
Interview with Bright Minds Biosciences’ CEO Ian McDonald
In today’s episode of the Psychedelic Spotlight podcast, the Psychedelic…
End of content
End of content